Loss of BAP1 is responsible for the process of malignant mesothelioma, and the homozygous deletion of BAP1 are associated with loss of IHC staining [32], thus leading to the high specificity of BAP1 in IHC. This evidence concerns the gene BAP1 and malignant mesothelioma.